GleamWall
中文EN

HYPR Hyperfine, Inc.

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1833769 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY80.0%
TTM net income YoY25.6%
TTM EPS YoY44.2%
Revenue 3-yr CAGR25.0%
Net income 3-yr CAGR—

Margins

Gross margin52.6%
Operating margin-167.6%
Net margin-156.4%
FCF margin-146.5%
EBITDA margin-162.0%

Returns

ROE-101.7%
ROA-60.0%
ROIC (approx.)-402.8%
Asset turnover0.38x

Leverage & solvency

Liabilities / assets45.1%
Debt / equity0.42x
Current ratio5.10x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.92x
Accruals ratio-4.5%
Payout ratio—
Capex / revenue1.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$5.96M$3.90M$3.90M$5.29M$3.44M$2.70M$2.14M$2.32M
Cost of revenue$2.58M$1.92M$1.92M$2.60M$1.59M$1.37M$1.25M$1.50M
Gross profit$3.38M$1.98M$1.98M$2.69M$1.85M$1.33M$883,000$826,000
R&D expense$3.91M$3.87M$3.85M$3.83M$4.05M$4.54M$5.04M$5.11M
SG&A expense$4.05M$3.91M$4.13M$4.03M$4.15M$3.86M$4.21M$4.13M
Operating income-$7.26M-$8.47M-$8.56M-$7.67M-$8.92M-$9.60M-$10.90M-$10.77M
Interest expense$549,000$533,000$83,000—$0$0$0—
Pretax income-$5.98M-$9.30M-$8.62M-$5.91M-$11.02M-$9.22M-$9.42M-$10.39M
Income tax$0$0$0$0$0$0$0$0
Net income-$5.98M-$9.30M-$8.62M-$5.91M-$11.02M-$9.22M-$9.42M-$10.39M
EBITDA-$7.01M-$8.21M-$8.28M-$7.39M-$8.62M-$9.31M-$10.67M-$10.53M
EPS (basic)-0.06-0.09-0.09—-0.14-0.12-0.12—
EPS (diluted)-0.06-0.09-0.09—-0.14-0.12-0.12—
Weighted avg. shares (diluted)106.11M99.80M97.70M—79.03M78.08M75.70M—
Balance sheet
Cash & equivalents$37.87M$43.46M$40.78M$35.09M$21.56M$25.42M$33.09M$37.67M
Receivables$5.18M$4.22M$3.79M$5.25M$4.89M$5.06M$5.33M$5.96M
Inventory$6.38M$6.79M$6.33M$7.09M$5.84M$4.88M$4.64M$5.83M
Current assets$53.75M$59.24M$56.03M$50.91M$36.90M$40.10M$48.40M$53.71M
PP&E, net$2.09M$2.26M$2.50M$2.55M$2.75M$3.12M$3.09M$3.12M
Total assets$57.79M$63.00M$60.34M$55.26M$41.51M$45.23M$53.38M$58.90M
Current liabilities$10.53M$9.63M$10.15M$11.73M$10.17M$7.99M$7.98M$8.73M
Short-term debt$0$0$0—————
Long-term debt$13.35M$13.23M$13.12M$0————
Total debt$13.35M$13.23M$13.12M$0————
Total liabilities$26.05M$26.24M$25.98M$14.26M$14.64M$10.11M$10.26M$9.86M
Shareholders' equity$31.74M$36.76M$34.36M$41.01M$26.87M$35.13M$43.11M$49.04M
Net debt-$24.52M-$30.22M-$27.66M-$35.09M————
Cash flow statement
Operating cash flow-$6.08M-$7.27M-$9.01M-$5.21M-$5.58M-$7.91M-$9.25M-$8.36M
Capital expenditure$21,000$30,000$242,000$63,000$130,000$520,000$472,000$8,000
Free cash flow-$6.10M-$7.30M-$9.25M-$5.27M-$5.71M-$8.43M-$9.72M-$8.37M
Investing cash flow-$21,000-$30,000-$242,000-$63,000-$130,000-$520,000-$472,000-$8,000
Financing cash flow-$10,000$10.78M$14.49M$19.28M$2.16M$474,000$5.58M$54,000
Depreciation & amortization$251,000$264,000$274,000$281,000$297,000$283,000$229,000$234,000
Stock-based compensation$962,000$903,000$647,000$692,000$617,000$547,000$945,000$1.05M

Free plan shows the latest 8 periods; Pro shows all 23 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.